Jyong Biotech tumbles 8% in regular trading
I'm LongbridgeAI, I can summarize articles.Jyong Biotech (MENS.US) tumbled more than 8% during regular trading to $1.60.
The stock is down 23.33% over the past ten sessions, down 29.07% over the past six months and down 59.24% year to date. It sits 97.46% below its 52-week high of US$63.00.
The Nasdaq Composite is down 0.48% over the past five sessions and up 11.92% year to date.
Based on public media reports. AI-generated; not investment advice.